EVFM logo

Evofem Biosciences, Inc. Stock Price

OTCPK:EVFM Community·US$1.2m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

EVFM Share Price Performance

US$0.0083
-0.00 (-8.79%)
US$0.0083
-0.00 (-8.79%)
Price US$0.0083

EVFM Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Moderate risk with questionable track record.

5 Risks
2 Rewards

Evofem Biosciences, Inc. Key Details

US$20.2m

Revenue

US$4.6m

Cost of Revenue

US$15.6m

Gross Profit

US$15.3m

Other Expenses

US$274.0k

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
0.0021
77.12%
1.36%
-78.3%
View Full Analysis

About EVFM

Founded
n/a
Employees
29
CEO
Saundra Pelletier
WebsiteView website
www.evofem.com

Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women’s sexual and reproductive health. The company’s commercial products include PHEXXI, a hormone-free contraceptive vaginal gel; and SOLOSEC, a single-dose oral antimicrobial agent for the treatment of bacterial vaginosis and trichomoniasis. Evofem Biosciences, Inc. is headquartered in San Diego, California.

Recent EVFM News & Updates

Recent updates

No updates